Regular coffee drinkers have 'cleaner' arteries March 2015
Caffeine may counter age-related inflammation
Coffee May Lower Your Risk of Dementia
Drinking Coffee Can Lower Alzheimer's Risk By 20%, All It Takes Is 3 Cups A Day
J-shaped relationship between habitual coffee consumption and 10-year (2002-2012) cardiovascular disease incidence: The ATTICA study
European Journal of Nutrition
Kouli GM, et al.
The objective of the study
portrayed in this paper was to assess the relationship between coffee
intake and 10–year cardiovascular disease (CVD) incidence in the ATTICA
study, and whether this is modified by the presence or absence of
metabolic syndrome (MetS) at baseline. This information supports the
protective impact of drinking moderate quantities of coffee (equivalent
to approximately 1–2 cups daily) against CVD incidents. This protective
impact was only significant for participants without MetS at baseline.
Methods
- A sum of 3042 healthy adults (1514 men and 1528 women) living in the greater area of Athens were voluntarily selected to the ATTICA study amid 2001–2002.
- In 2011–2012, the 10–year follow–up was performed in 2583 participants (15% of the participants were lost to follow–up).
- Coffee intake was evaluated by a validated food–frequency questionnaire at baseline (abstention, low, moderate, heavy).
- Incidence of fatal or non–fatal CVD event was recorded utilizing WHO–ICD–10 criteria and MetS was characterized by the National Cholesterol Education Program Adult Treatment panel III (revised) criteria.
Results
- Overall, after controlling for potential CVD risk factors, the multivariate examination uncovered a J–shaped relationship between daily coffee drinking and the risk for a first CVD event in a 10–year period.
- Especially, the odds ratio for low (<150 ml/day), moderate (150–250 ml/day) and heavy coffee intake (>250 ml/day), compared to abstention, were 0.44 (95% CI 0.29–0.68), 0.49 (95% CI 0.27–0.92) and 2.48 (95% CI 1.56–1.93), respectively.
- This inverse association was also verified among participants without MetS at baseline, but not among participants with the MetS.
No comments:
Post a Comment